Benzocaine
| Benzocaine | |
|---|---|
| Salts [] | |
|---|---|
| Benzocaine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 165.19 g/mol [1] |
| Appearance | Rhombohedra from ether [1] |
| Melting point | 92 °C [1] |
| Boiling point | 310 °C [1] |
| Solubility | 1310 mg/L (at 30 °C) [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H11NO2 |
| IUPAC name | ethyl 4-aminobenzoate |
| SMILES | CCOC(=O)C1=CC=C(C=C1)N |
| InChI | InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3 |
| InChIKey | BLFLLBZGZJTVJG-UHFFFAOYSA-N |
| CAS number | 94-09-7 |
| UNII | U3RSY48JW5 |
| PubChem CID | 2337 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Topical, Oral |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - Oral: 3040 mg/kg [1] |
Benzocaine (also known as Ethyl p-aminobenzoate, Anaesthesin, Americaine, Norcaine, Parathesin, Ethyl aminobenzoate, Parathesine, 4-Aminobenzoic acid ethyl ester, Topcaine or Anesthesin) is a anaesthetic and sodium channel blocker substance of the aniline class.
Chemistry
Salts []
Benzocaine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Benzocaine is achiral.
Druglikeness
Lipinski's rule of five
Benzocaine matches Lipinski's rule of five.Reagents
There are currently 10 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | light orange-brown | |
| Liebermann | no color change | |
| Froehde | no color change | |
| Robadope | no pink color change | |
| Ehrlich | orange | |
| Hofmann | yellow | |
| Scott | no color change | |
| Morris | no color change |
Pharmacology
ATC Classification
- cardiovascular system (C)
- vasoprotectives (C05)
- agents for treatment of hemorrhoids and anal fissures for topical use (C05A)
- local anesthetics (C05AD)
- (C05AD03)
- benzocaine (C05AD03)
- dermatologicals (D)
- antipruritics, incl. antihistamines, anesthetics, etc. (D04)
- antipruritics, incl. antihistamines, anesthetics, etc. (D04A)
- anesthetics for topical use (D04AB)
- benzocaine (D04AB04)
- nervous system (N)
- anesthetics (N01)
- anesthetics, local (N01B)
- esters of aminobenzoic acid (N01BA)
- benzocaine (N01BA05)
- respiratory system (R)
- throat preparations (R02)
- throat preparations (R02A)
- anesthetics, local (R02AD)
- benzocaine (R02AD01)
MeSH Classification
Mechanism of action []
Benzocaine diffuses into nerve cells where it binds to sodium channels, preventing the channels from opening, and blocking the influx of sodium ions. Nerve cells unable to allow sodium into cells cannot depolarize and conduct nerve impulses. [1]
Interactions []
Medical side effects []
16 side effects listed on drug labels in SIDER 4.1 (benzocaine).
- Cyanosis
- Dermatitis contact
- Dyspnoea
- Oedema
- Dermatitis
- Rash
- Hypersensitivity
- Methaemoglobinaemia
- Pruritus
- Swelling
- Erythema
- Redness
- Urticaria
- Tenderness
- Respiratory distress
- Oral discomfort
Indications
- Acute swimmers' ear
- Discomfort
- Ear pain
- Otitis externa
- Otitis media acute
Subjective effects []
| 0xea / Benzocaine [] | |
|---|---|
Routes:
| |
| emily / Benzocaine [] | |
|---|---|
Routes:
| |
| Pilz / Benzocaine [] | |
|---|---|
Routes:
| |
Legal status []
- Australia: Benzocaine is a S4 / Schedule 2.[3]
- United Kingdom: Benzocaine is a GSL, P.
- United States: Benzocaine is a OTC.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2337, Benzocaine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2337
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Benzocaine. UNII: U3RSY48JW5. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/U3RSY48JW5
Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025. Therapeutic Goods Administration (TGA). May 2025. https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:01:58 |
| drugspro | ok | 2026-11-20 14:01:54 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 14:01:54 |
| gsrs | ok | 2026-11-20 14:01:55 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0004992) | 2026-11-20 14:01:54 |
| kegg | ok | 2026-11-20 14:01:55 |
| pubchem | ok | 2026-11-20 14:01:54 |
| missing (no r/tripreports posts mention it) | 2026-11-20 14:01:54 | |
| sider | ok | 2026-11-20 14:01:54 |
| structure | ok | 2026-11-20 14:01:54 |
| wikipedia | ok | 2026-11-20 14:01:54 |